DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "North America Non-Vascular Stents Market Outlook to 2023" report to their offering.
The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Pancreatic and Biliary Stents, Enteral Stents, Airway Stents and Urinary Tract Stents.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the North America Non-Vascular Stents market.
- Key players covered include Boston Scientific Corp, C. R. Bard Inc, W. L. Gore & Associates Inc and Others.
Key Topics Covered:
1 Table of Contents
3 Non-Vascular Stents Market, North America
4 Non-Vascular Stents Market, Canada
5 Non-Vascular Stents Market, Mexico
6 Non-Vascular Stents Market, United States
7 Overview of Key Companies in North America Non-Vascular Stents Market
- Boston Scientific Corp
- C. R. Bard Inc
- Taewoong Medical Co.,Ltd.
- Cook Group Inc
- W. L. Gore & Associates Inc
- Allium Medical Solutions Ltd
For more information about this report visit http://www.researchandmarkets.com/research/qt7672/north_america